Is RVXCF or DIVO a better dividend investment in 2026?

RVXCF currently yields 2298.85% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: RVXCF offers higher current income.

What is the dividend yield difference between RVXCF and DIVO?

RVXCF has a forward dividend yield of 2298.85% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 2292.36 percentage points.

Home › Compare › RVXCF vs DIVO

RVXCF vs DIVO: Dividend Comparison 2026

RVXCF yields 2298.85% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RVXCF wins by $36577739038.82M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RVXCF

● Live price

2298.85%

Share price

$0.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$36577739038.85M

Annual income

$33,694,466,973,692,370.00

Full RVXCF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — RVXCF vs DIVO

📍 RVXCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RVXCF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RVXCF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RVXCF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RVXCF

Annual income on $10K today (after 15% tax)

$195,402.30/yr

After 10yr DRIP, annual income (after tax)

$28,640,296,927,638,510.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, RVXCF beats the other by $28,640,296,927,637,676.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RVXCF + DIVO for your $10,000?

RVXCF: 50%DIVO: 50%

100% DIVO50/50100% RVXCF

Portfolio after 10yr

$18288869519.44M

Annual income

$16,847,233,486,846,674.00/yr

Blended yield

92.12%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RVXCF buys

DIVO buys

No recent congressional trades found for RVXCF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRVXCFDIVO

Forward yield	2298.85% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$36577739038.85M ✓	$30.7K
Annual income after 10y	$33,694,466,973,692,370.00 ✓	$981.68
Total dividends collected	$36375156338.99M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RVXCF vs DIVO ($10,000, DRIP)

Year	RVXCF Portfolio	RVXCF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$240,585	$229,885.06	$11,349	$649.42	+$229.2K → RVXCF
2	$5,426,296	$5,168,870.07	$12,833	$688.83	+$5.41M → RVXCF
3	$114,761,014	$108,954,877.01	$14,459	$727.90	+$114.75M → RVXCF
4	$2,276,338,467	$2,153,544,182.26	$16,238	$766.49	+$2276.32M → RVXCF
5	$42,357,698,654	$39,922,016,494.37	$18,179	$804.47	+$42357.68M → RVXCF
6	$739,586,041,815	$694,263,304,255.43	$20,293	$841.71	+$739586.02M → RVXCF
7	$12,120,492,876,395	$11,329,135,811,652.31	$22,591	$878.14	+$12120492.85M → RVXCF
8	$186,486,946,005,072	$173,518,018,627,329.40	$25,087	$913.65	+$186486945.98M → RVXCF
9	$2,694,646,789,868,656	$2,495,105,757,643,229.00	$27,791	$948.18	+$2694646789.84M → RVXCF
10	$36,577,739,038,851,830	$33,694,466,973,692,370.00	$30,718	$981.68	+$36577739038.82M → RVXCF

RVXCF vs DIVO: Complete Analysis 2026

RVXCF — Stock

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.

Full RVXCF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this RVXCF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RVXCF vs SCHD RVXCF vs JEPI RVXCF vs O RVXCF vs KO RVXCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.